Richard Williams, David Jenkins, Thomas Bolton, Adrian Heald, Mehrdad A Mizani, Matthew Sperrin, Niels Peek, CVD-COVID-UK/COVID-IMPACT Consortium
{"title":"在英格兰国家数据库中复制 COVID-19 研究,以评估地区电子健康记录数据研究的普遍性","authors":"Richard Williams, David Jenkins, Thomas Bolton, Adrian Heald, Mehrdad A Mizani, Matthew Sperrin, Niels Peek, CVD-COVID-UK/COVID-IMPACT Consortium","doi":"10.1101/2024.08.06.24311538","DOIUrl":null,"url":null,"abstract":"Introduction\nThe replication of observational studies using electronic health record data is critical for the evidence base of epidemiology. We have previously performed a study using linked primary and secondary care data in a large, urbanised region (Greater Manchester Care Record, Greater Manchester, UK) to compare the hospitalization rates of patients with diabetes (type 1 or type 2) after contracting COVID-19 with matched controls.\nMethods\nIn this study we repeated the analysis using a national database covering the whole of England, UK (NHS England's Secure Data Environment service for England, accessed via the BHF Data Science Centre's CVD-COVID-UK/COVID-IMPACT Consortium).\nResults\nWe found that many of the effect sizes did not show a statistically significant difference. Where effect sizes were statistically significant in the regional study, then they remained significant in the national study and the effect size was the same direction and of similar magnitude.\nConclusion\nThere is some evidence that the findings from studies in smaller regional datasets can be extrapolated to a larger, national setting. However, there were some significant differences and therefore replication studies remain an essential part of healthcare research.","PeriodicalId":501454,"journal":{"name":"medRxiv - Health Informatics","volume":"44 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Replicating a COVID-19 study in a national England database to assess the generalisability of research with regional electronic health record data\",\"authors\":\"Richard Williams, David Jenkins, Thomas Bolton, Adrian Heald, Mehrdad A Mizani, Matthew Sperrin, Niels Peek, CVD-COVID-UK/COVID-IMPACT Consortium\",\"doi\":\"10.1101/2024.08.06.24311538\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction\\nThe replication of observational studies using electronic health record data is critical for the evidence base of epidemiology. We have previously performed a study using linked primary and secondary care data in a large, urbanised region (Greater Manchester Care Record, Greater Manchester, UK) to compare the hospitalization rates of patients with diabetes (type 1 or type 2) after contracting COVID-19 with matched controls.\\nMethods\\nIn this study we repeated the analysis using a national database covering the whole of England, UK (NHS England's Secure Data Environment service for England, accessed via the BHF Data Science Centre's CVD-COVID-UK/COVID-IMPACT Consortium).\\nResults\\nWe found that many of the effect sizes did not show a statistically significant difference. Where effect sizes were statistically significant in the regional study, then they remained significant in the national study and the effect size was the same direction and of similar magnitude.\\nConclusion\\nThere is some evidence that the findings from studies in smaller regional datasets can be extrapolated to a larger, national setting. However, there were some significant differences and therefore replication studies remain an essential part of healthcare research.\",\"PeriodicalId\":501454,\"journal\":{\"name\":\"medRxiv - Health Informatics\",\"volume\":\"44 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"medRxiv - Health Informatics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2024.08.06.24311538\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Health Informatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.08.06.24311538","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Replicating a COVID-19 study in a national England database to assess the generalisability of research with regional electronic health record data
Introduction
The replication of observational studies using electronic health record data is critical for the evidence base of epidemiology. We have previously performed a study using linked primary and secondary care data in a large, urbanised region (Greater Manchester Care Record, Greater Manchester, UK) to compare the hospitalization rates of patients with diabetes (type 1 or type 2) after contracting COVID-19 with matched controls.
Methods
In this study we repeated the analysis using a national database covering the whole of England, UK (NHS England's Secure Data Environment service for England, accessed via the BHF Data Science Centre's CVD-COVID-UK/COVID-IMPACT Consortium).
Results
We found that many of the effect sizes did not show a statistically significant difference. Where effect sizes were statistically significant in the regional study, then they remained significant in the national study and the effect size was the same direction and of similar magnitude.
Conclusion
There is some evidence that the findings from studies in smaller regional datasets can be extrapolated to a larger, national setting. However, there were some significant differences and therefore replication studies remain an essential part of healthcare research.